Siemens taps Weatherhead as marketing VP
Nuclear medicine veteran Randy Weatherhead has been named vicepresident of marketing for the nuclear medicine division of SiemensMedical Systems in Hoffman Estates, IL. Weatherhead fills a positionpreviously held by Robert Lytle, who died in a plane
Nuclear medicine veteran Randy Weatherhead has been named vicepresident of marketing for the nuclear medicine division of SiemensMedical Systems in Hoffman Estates, IL. Weatherhead fills a positionpreviously held by Robert Lytle, who died in a plane crash earlierthis year (SCAN 5/10/95).
Weatherhead joins Siemens after a two-year stint with ADACLaboratories, where he was senior marketing manager. Prior toADAC, he was vice president of marketing at Sopha Medical Systems.
Weatherhead said his goal at Siemens is to grow the nucleardivision's market share, which stands at 21% globally. He seesthe company's investments in detector technology and computerworkstations as particularly important.
"We have an extensive distribution system worldwide, withthe largest service organization of any nuclear medicine company,"Weatherhead said. "We should be able to increase our marketshare substantially over the next few years."
Photon-Counting Computed Tomography: Eleven Takeaways from a New Literature Review
May 27th 2025In a review of 155 studies, researchers examined the capabilities of photon-counting computed tomography (PCCT) for enhanced accuracy, tissue characterization, artifact reduction and reduced radiation dosing across thoracic, abdominal, and cardiothoracic imaging applications.
Can AI Predict Future Lung Cancer Risk from a Single CT Scan?
May 19th 2025In never-smokers, deep learning assessment of single baseline low-dose computed tomography (CT) scans demonstrated a 79 percent AUC for predicting lung cancer up to six years later, according to new research presented today at the American Thoracic Society (ATS) 2025 International Conference.
Can Emerging AI Software Offer Detection of CAD on CCTA on Par with Radiologists?
May 14th 2025In a study involving over 1,000 patients who had coronary computed tomography angiography (CCTA) exams, AI software demonstrated a 90 percent AUC for assessments of cases > CAD-RADS 3 and 4A and had a 98 percent NPV for obstructive coronary artery disease.
